| 3 Top Diabetes Stocks to Watch in August 10:05am / MotleyFool.com - Paid Partner Content | 8 Stocks That Have Paid a Dividend for 125 (or More) Consecutive Years Aug 13 / MotleyFool.com - Paid Partner Content |
| Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice 9:15am / Zacks.com - Paid Partner Content | Intrexon (XON) Reports Narrower-Than-Expected Loss in Q2 Aug 09 / Zacks.com - Paid Partner Content |
| Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco 8:56am / Zacks.com - Paid Partner Content | Nektar (NKTR) Q2 Earnings Beat Estimates, Revenues Miss Aug 09 / Zacks.com - Paid Partner Content |
| Bayer Sells Animal Health Division to Elanco: Now What? Aug 20 / Zacks.com - Paid Partner Content | Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Aug 09 / Zacks.com - Paid Partner Content |
| Better Buy: Eli Lilly vs. GlaxoSmithKline Aug 18 / MotleyFool.com - Paid Partner Content | Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates Aug 09 / Zacks.com - Paid Partner Content |
| Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY Aug 16 / Zacks.com - Paid Partner Content | Top Stock Reports: Disney, Eli Lilly, ADP & More Aug 08 / Zacks.com - Paid Partner Content |
| Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe Aug 16 / Zacks.com - Paid Partner Content | Celldex (CLDX) Q2 Loss Narrower Than Expected, Revenues Miss Aug 08 / Zacks.com - Paid Partner Content |
| Agios Rides High on Tibsovo Sales Amid Acute Competition Aug 15 / Zacks.com - Paid Partner Content | Radius (RDUS) Q2 Earnings Beat Estimates, Tymlos Sales Solid Aug 08 / Zacks.com - Paid Partner Content |
| Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Aug 14 / Zacks.com - Paid Partner Content | Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down Aug 08 / Zacks.com - Paid Partner Content |
| Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study Aug 14 / Zacks.com - Paid Partner Content | |
+0.93 / +0.84%